Literature DB >> 27416577

HyperLp(a)lipoproteinaemia: unmet need of diagnosis and treatment?

Claudia Stefanutti1, Claudia Morozzi1.   

Abstract

Mesh:

Year:  2016        PMID: 27416577      PMCID: PMC5016299          DOI: 10.2450/2016.0027-16

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  37 in total

Review 1.  Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity.

Authors:  Marlys L Koschinsky; Santica M Marcovina
Journal:  Curr Opin Lipidol       Date:  2004-04       Impact factor: 4.776

2.  Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.

Authors:  Pia R Kamstrup; Anne Tybjærg-Hansen; Børge G Nordestgaard
Journal:  J Am Coll Cardiol       Date:  2013-10-23       Impact factor: 24.094

Review 3.  Lipoprotein(a)--An independent causal risk factor for cardiovascular disease and current therapeutic options.

Authors:  Ursula Kassner; Thomas Schlabs; Adrian Rosada; Elisabeth Steinhagen-Thiessen
Journal:  Atheroscler Suppl       Date:  2015-05       Impact factor: 3.235

4.  Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.

Authors:  G Utermann; H J Menzel; H G Kraft; H C Duba; H G Kemmler; C Seitz
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

5.  Does regular lipid apheresis in patients with isolated elevated lipoprotein(a) levels reduce the incidence of cardiovascular events?

Authors:  Adrian Rosada; Ursula Kassner; Anja Vogt; Michael Willhauck; Klaus Parhofer; Elisabeth Steinhagen-Thiessen
Journal:  Artif Organs       Date:  2013-07-25       Impact factor: 3.094

6.  In vivo transfer of lipoprotein(a) into human atherosclerotic carotid arterial intima.

Authors:  L B Nielsen; M L Grønholdt; T V Schroeder; S Stender; B G Nordestgaard
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-05       Impact factor: 8.311

7.  Lipoprotein[a] as a risk factor for preclinical atherosclerosis.

Authors:  P J Schreiner; J D Morrisett; A R Sharrett; W Patsch; H A Tyroler; K Wu; G Heiss
Journal:  Arterioscler Thromb       Date:  1993-06

8.  Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid pattern.

Authors:  M von Dryander; S Fischer; J Passauer; G Müller; S R Bornstein; U Julius
Journal:  Atheroscler Suppl       Date:  2013-01       Impact factor: 3.235

9.  Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study.

Authors:  Pia R Kamstrup; Marianne Benn; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

Review 10.  Lipoprotein(a) as a risk factor for coronary artery disease.

Authors:  S M Marcovina; M L Koschinsky
Journal:  Am J Cardiol       Date:  1998-12-17       Impact factor: 2.778

View more
  2 in total

Review 1.  Looking at Lp(a) and Related Cardiovascular Risk: from Scientific Evidence and Clinical Practice.

Authors:  Thomas M Stulnig; Claudia Morozzi; Roman Reindl-Schwaighofer; Claudia Stefanutti
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

2.  Incidence of elevated lipoprotein (a) levels in a large cohort of patients with cardiovascular disease.

Authors:  Frank van Buuren; Dieter Horstkotte; Cornelius Knabbe; Dennis Hinse; Klaus Peter Mellwig
Journal:  Clin Res Cardiol Suppl       Date:  2017-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.